pocketful logo
Prism Medico & Pharmacy Ltd logo

Prism Medico & Pharmacy Ltd

NSE: BSE: 512217

₹24.75

(4.96%)

Thu, 12 Mar 2026, 01:41 am

mtf coin illustrationMTF 5x

Prism Medico & Pharmacy Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    15.01

  • Net Profit

    -0.05

  • P/B

    1.74

  • Sector P/E

    56.81

  • P/E

    528.57

  • EV/EBITDA

    61.76

  • Debt/Equity (Industry)

    0.65

  • Interest Cover (Industry)

    4.79

  • ROCE (Industry)

    18.39

  • RONW (Industry)

    17.80

  • ROE

    1.09

  • ROCE

    1.57

  • Debt/Equity

    0.17

  • EPS (TTM)

    0.99

  • Dividend Yield

    0

  • Book Value

    24.89

  • Interest Cover

    2.17

Analysis

all

thumbs up icon

Pros

  • Prism Medico and Pharmacy is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Prism Medico and Pharmacy has been profitable on average in the past, therefore cash runway is not a concern.
  • Prism Medico and Pharmacy has been profitable on average in the past, therefore cash runway is not a concern.
  • Prism Medico and Pharmacy has no debt, it does not need to be covered by operating cash flow.
  • Prism Medico and Pharmacy has no debt, it does not need to be covered by short term assets.
thumbs up icon

Cons

  • Unable to evaluate Prism Medico and Pharmacy's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Prism Medico and Pharmacy's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • High level of physical assets or inventory.
  • The average tenure for the Prism Medico and Pharmacy board of directors is less than 3 years, this suggests a new board.
  • Prism Medico and Pharmacy is not covered by any analysts.

Read More

Financials

No Result Found

Read More

Ratios

No Result Found

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters25.0025.0025.0025.0025.00
FII00000
DII00000
Public75.0075.0075.0075.0075.00
Government00000

Read More

Technical Analysis

RSI

-

MACD

-

50 DMA

-

200 DMA

-

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic-------
Fibonacci-------
Camarilla-------

Pivots Level: Classic

R3

+-

-

R2

+-

-

R1

+-

-

-
-
Pivot Point
LTP: -

S1

--

-

S2

--

-

S3

--

-

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    -

  • 20-EMA

    -

  • 30-EMA

    -

  • 50-EMA

    -

  • 100-EMA

    -

  • 200-EMA

    -

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
23 Feb 2026egm
13 Feb 2026board-meetingsQuarterly Results
14 Nov 2025board-meetingsQuarterly Results
05 Sept 2025agm
17 Sept 2024agm
04 Sept 2023agm
20 Jul 2023egm
21 Sept 2022agm
30 Dec 2021egm
23 Aug 2021agm

Read More

Peer Comparison

No Result Found

Prism Medico & Pharmacy Ltd logo

Prism Medico & Pharmacy Ltd

Aegis Logistics Ltd logo

Aegis Logistics Ltd

Redington Ltd logo

Redington Ltd

Honasa Consumer Ltd logo

Honasa Consumer Ltd

Premier Energies Ltd logo

Premier Energies Ltd

Adani Enterprises Ltd logo

Adani Enterprises Ltd

Read More

Prism Medico & Pharmacy Ltd About

Prism Medico and Pharmacy engaged in wholesale and retail altering its Memorandum of Association to enter the pharmaceutical and healthcare sectors. Its current activities include manufacturing, processing, and trading pharmaceuticals, antibiotics, nutraceuticals, and other health-related products for both domestic and international markets.

Industry

Trading

Founded

2002

Headquarters

CEO

Employees

Contact

Website icon

Website

http://www.prismmedico.in

Email icon

Email

investorgrievancewmcl@gmail.com

Phone icon

Phone

0172-5020762

Location icon

Location

D-118 Industrial Area, Phase VII, Mohali, Punjab, 160055

Read More

Prism Medico & Pharmacy Ltd Company History

YearHistory
2002
  • The company was incorporated.
2010
  • The Registered Office of the Company was shifted to E-18, 6th Floor, Everest Bldg, Tardeo, Mumbai - 400 034.
2012
  • The company changed its name from Woolite Mercantile Co.Ltd. to Prism Medico and Pharmacy Ltd.
2014
  • The Board of Directors appointed Mr. Sachin Sharma as an Executive Director.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
DILSHAD ALAMBuy3200024.711 Mar 2026
ADITHYA JAINSell2700025.7706 Mar 2026
EMILY BOSCO MENEZESBuy5000023.4706 Mar 2026
AKASH GOYALSell3684024.0706 Mar 2026
AKASH GOYALBuy3684023.7106 Mar 2026
ADITHYA JAINBuy3561323.4906 Mar 2026
NEO APEX SHARE BROKING SERVICES LLPSell20212623.5206 Mar 2026
BOSCO ARMANDO MENEZESBuy5000023.4706 Mar 2026
SUKHA SINGHBuy5000025.7706 Mar 2026
NEO APEX SHARE BROKING SERVICES LLPSell3813424.705 Mar 2026

Read More

Prism Medico & Pharmacy Ltd News

Prism Medico Board Approves Rs. 25 Crore Equity Issue

Prism Medico and Pharmacy Limited board approved issuance of 75 lakh equity shares and 50 lakh convertible warrants at Rs. 20 each, raising Rs. 25 crore through preferential allotment.

23 Feb 2026

co actions results

Prism Medico Board Meet Set for Feb 13 Q3 Results

Prism Medico and Pharmacy Limited has scheduled its board meeting for February 13, 2026, to consider and approve Q3FY26 unaudited standalone financial results for quarter ended December 31, 2025.

07 Feb 2026

co actions results

Prism Medico Files Q3FY26 Depositories Compliance

Prism Medico and Pharmacy Limited submitted confirmation certificate under SEBI Depositories Regulations for Q3FY26 quarter ended December 31, 2025, with no dematerialisation activity.

14 Jan 2026

stocks

Prism Medico Reports Mixed Quarterly Results with Rs 8.48 Lakh Loss Despite Strong Half-Year Performance

Prism Medico and Pharmacy Limited reported a net loss of Rs 8.48 lakh for the quarter ended September 30, 2025, contrasting with a strong half-year profit of Rs 57.25 lakh driven by significant revenue growth in the previous quarter. The company also corrected a filing error by re-uploading financial statements after inadvertently omitting Statement of Assets and Liabilities and Cash Flow Statement from the original PDF submission to stock exchanges.

21 Nov 2025

earnings

Prism Medico and Pharmacy Limited Reports Strong Quarterly Performance with 65.73 Lakh Net Profit

Prism Medico and Pharmacy Limited's Board of Directors approved unaudited standalone financial results for the quarter ended June 30, 2025. The company reported revenue from operations of 158.87 lakhs, a significant increase from 7.28 lakhs in the previous quarter and 6.27 lakhs in the corresponding quarter last year. Net profit for the quarter reached 65.73 lakhs, compared to 4.15 lakhs in the previous quarter and a loss of 9.00 lakhs in the year-ago period. Total expenses were 93.84 lakhs, with cost of materials consumed being the largest component at 85.75 lakhs. The company's earnings per share improved to 0.0108 rupees from 0.0007 rupees in the previous quarter. The paid-up equity share capital remained stable at 606.34 lakhs. The results were reviewed by auditors Garg Mendiratta & Associates and approved by the Board at a meeting held on August 14, 2025.

12 Sept 2025

earnings

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800